Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada
· Delayed Price · Currency is CAD 9.77
-0.10 (-1.01%)
Apr 28, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 600.89 million as of April 28, 2026. Its market cap has increased by 306.83% in one year.
Market Cap
600.89M
Enterprise Value
529.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.77
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 600.89M, an increase of 670.30%. That is a compound annual growth rate of 48.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 607.04M | 16.14% |
| Dec 31, 2025 | 522.69M | 225.34% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.19B |
| Satellos Bioscience | 204.98M |
| Helix BioPharma | 144.35M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 63.16M |
| Sernova Biotherapeutics | 61.45M |
| NurExone Biologic | 56.15M |
| Medicenna Therapeutics | 50.89M |